BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27041932)

  • 1. Intraductal carcinoma of prostate (IDC-P): from obscure to significant.
    Chen N; Zhou Q
    Chin J Cancer Res; 2016 Feb; 28(1):99-106. PubMed ID: 27041932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal carcinoma of the prostate: What we know and what we do not know.
    Chen X; Ding B; Zhang P; Geng S; Xu J; Han B
    Pathol Res Pract; 2018 May; 214(5):612-618. PubMed ID: 29628124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
    Montironi R; Zhou M; Magi-Galluzzi C; Epstein JI
    Eur Urol Oncol; 2018 May; 1(1):21-28. PubMed ID: 31100224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal carcinoma of the prostate.
    Robinson B; Magi-Galluzzi C; Zhou M
    Arch Pathol Lab Med; 2012 Apr; 136(4):418-25. PubMed ID: 22458904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
    Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
    Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
    Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
    Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal carcinoma of the prostate: the whole story.
    Zhou M
    Pathology; 2013 Oct; 45(6):533-9. PubMed ID: 24018805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal carcinoma of prostate: a comprehensive and concise review.
    Roberts JA; Zhou M; Park YW; Ro JY
    Korean J Pathol; 2013 Aug; 47(4):307-15. PubMed ID: 24009625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma.
    Shah RB; Yoon J; Liu G; Tian W
    Histopathology; 2017 Nov; 71(5):693-702. PubMed ID: 28570007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
    Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ
    Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate.
    Shah RB; Zhou M
    Adv Anat Pathol; 2012 Jul; 19(4):270-8. PubMed ID: 22692290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of intraductal carcinoma of the prostate and associated lesions in the cancer foci on radical prostatectomy specimens].
    Sakamoto N; Maki T; Kobayashi S; Kobayashi T; Hamaguchi M; Yoshikawa M; Iguchi A; Momosaki S; Nakayama Y
    Nihon Hinyokika Gakkai Zasshi; 2014 Oct; 105(4):163-70; discussion 171. PubMed ID: 25757345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
    Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G
    J Clin Pathol; 2016 Oct; 69(10):852-7. PubMed ID: 26926101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.
    Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U
    Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
    Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study of the incidence and survival for intraductal carcinoma of the prostate.
    Dinerman BF; Khani F; Golan R; Bernstein AN; Cosiano MF; Margolis DJ; Hu JC
    Urol Oncol; 2017 Dec; 35(12):673.e9-673.e14. PubMed ID: 28919182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
    Chua MLK; Lo W; Pintilie M; Murgic J; Lalonde E; Bhandari V; Mahamud O; Gopalan A; Kweldam CF; van Leenders GJLH; Verhoef EI; Hoogland AM; Livingstone J; Berlin A; Dal Pra A; Meng A; Zhang J; Orain M; Picard V; Hovington H; Bergeron A; Lacombe L; Fradet Y; TĂȘtu B; Reuter VE; Fleshner N; Fraser M; Boutros PC; van der Kwast TH; Bristow RG
    Eur Urol; 2017 Nov; 72(5):665-674. PubMed ID: 28511883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.